187 related articles for article (PubMed ID: 36067639)
1. Generation of two induced pluripotent stem cell lines (RCMGi005-A/B) from human skin fibroblasts of a cystic fibrosis patient with homozygous F508del mutation in CFTR gene.
Panchuk I; Kondrateva E; Demchenko A; Grigorieva O; Erofeeva A; Amelina E; Tabakov V; Orlova M; Voronina E; Pozhitnova V; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2022 Oct; 64():102896. PubMed ID: 36067639
[TBL] [Abstract][Full Text] [Related]
2. Generation of induced pluripotent stem cell line (RCMGi008-A) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/CFTRdele2.3 mutations in CFTR gene.
Kondrateva E; Panchuk I; Demchenko A; Grigorieva O; Zheglo D; Voronina E; Erofeeva A; Tabakov V; Orlova M; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2022 Aug; 63():102854. PubMed ID: 35843019
[TBL] [Abstract][Full Text] [Related]
3. Generation of two induced pluripotent stem cell lines (RCMGi004-A and -B) from human skin fibroblasts of a cystic fibrosis patient with compound heterozygous F508del/W1282X mutations in CFTR gene.
Kondrateva E; Demchenko A; Slesarenko Y; Pozhitnova V; Yasinovsky M; Amelina E; Tabakov V; Voronina E; Lavrov A; Smirnikhina S
Stem Cell Res; 2021 Apr; 52():102232. PubMed ID: 33607467
[TBL] [Abstract][Full Text] [Related]
4. Generation of two induced pluripotent stem cell (iPSC) lines from p.F508del Cystic Fibrosis patients.
Fleischer A; Lorenzo IM; Palomino E; Aasen T; Gómez F; Servera M; Asensio VJ; Gálvez V; Izpisúa-Belmonte JC; Bachiller D
Stem Cell Res; 2018 May; 29():1-5. PubMed ID: 29554588
[TBL] [Abstract][Full Text] [Related]
5. Generation of induced pluripotent stem cell line (RCMGi001-A) from human skin fibroblasts of a cystic fibrosis patient with p.F508del mutation.
Kondrateva E; Adilgereeva E; Amelina E; Tabakov V; Demchenko A; Ustinov K; Yasinovsky M; Voronina E; Lavrov A; Smirnikhina S
Stem Cell Res; 2020 Oct; 48():101933. PubMed ID: 32777768
[TBL] [Abstract][Full Text] [Related]
6. Generation of two induced pluripotent stem cells lines from a Mucopolysaccharydosis IIIB (MPSIIIB) patient.
Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Bachiller D
Stem Cell Res; 2018 Dec; 33():180-184. PubMed ID: 30408744
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell line (IGGi002A) from nasal cells of a cystic fibrosis patient homozygous for the G542X-CFTR mutation.
Dębczyński M; Mojsak D; Tamburro S; Baldassari S; Musante I; Casciaro R; Ciciriello F; Zara F; Scudieri P; Gorrieri G
Stem Cell Res; 2023 Oct; 72():103232. PubMed ID: 37865062
[TBL] [Abstract][Full Text] [Related]
8. Derivation of iPSC line (RCMGi002-A) from dermal fibroblasts of a cystic fibrosis female patient with homozygous F508del mutation.
Kondrateva E; Demchenko A; Slesarenko Y; Yasinovsky M; Amelina E; Tabakov V; Voronina E; Lavrov A; Smirnikhina S
Stem Cell Res; 2021 May; 53():102251. PubMed ID: 33684631
[TBL] [Abstract][Full Text] [Related]
9. Modeling Cystic Fibrosis Using Pluripotent Stem Cell-Derived Human Pancreatic Ductal Epithelial Cells.
Simsek S; Zhou T; Robinson CL; Tsai SY; Crespo M; Amin S; Lin X; Hon J; Evans T; Chen S
Stem Cells Transl Med; 2016 May; 5(5):572-9. PubMed ID: 27034411
[TBL] [Abstract][Full Text] [Related]
10. Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells.
Crane AM; Kramer P; Bui JH; Chung WJ; Li XS; Gonzalez-Garay ML; Hawkins F; Liao W; Mora D; Choi S; Wang J; Sun HC; Paschon DE; Guschin DY; Gregory PD; Kotton DN; Holmes MC; Sorscher EJ; Davis BR
Stem Cell Reports; 2015 Apr; 4(4):569-77. PubMed ID: 25772471
[TBL] [Abstract][Full Text] [Related]
11. Reprogramming of dermal fibroblasts from a Duchenne muscular dystrophy patient carrying a deletion of exons 45-50 into an induced pluripotent stem cell line (CCMi005-A).
Rovina D; Castiglioni E; Mallia S; Rabino M; Farini A; Belicchi M; Di Giuseppe G; Gervasini C; Torrente Y; Pompilio G; Gowran A
Stem Cell Res; 2022 Oct; 64():102889. PubMed ID: 35961103
[TBL] [Abstract][Full Text] [Related]
12. Generation of human induced pluripotent stem cells from cystic fibrosis patient carrying nonsense mutation (p.S308X) in CFTR gene.
Khor W; Hwang TC; Wang CC; Yarmishyn AA; Yeh JT; Chiou SH; Chou SJ
Stem Cell Res; 2022 Apr; 60():102683. PubMed ID: 35091309
[TBL] [Abstract][Full Text] [Related]
13. Generation of four patient-specific pluripotent induced stem cell lines from two Brazilian patients with amyotrophic lateral sclerosis and two healthy subjects.
Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
Stem Cell Res; 2019 May; 37():101448. PubMed ID: 31077962
[TBL] [Abstract][Full Text] [Related]
14. Generation of patient-specific induced pluripotent stem cell lines from one patient with Jervell and Lange-Nielsen syndrome, one with type 1 long QT syndrome and two healthy relatives.
Kasai-Brunswick TH; Silva Dos Santos D; Ferreira RP; Araujo DS; Dias GM; Coutinho JLA; Cruz FESF; Sternick EB; Gubert F; Oliveira JCG; Vaz IM; Borgonovo T; Brofman PRS; Moura-Neto RS; Silva R; Campos-de-Carvalho AC; Carvalho AB
Stem Cell Res; 2018 Aug; 31():174-180. PubMed ID: 30099333
[TBL] [Abstract][Full Text] [Related]
15. Generation of patient-specific pluripotent induced stem cell line UFRJi007-A from a Brazilian familial amyotrophic lateral sclerosis patient.
Gubert F; Vasques JF; Cozendey TD; Domizi P; Toledo MF; Kasai-Brunswick TH; Hochman-Mendez C; Junior MC; Zembrzuski VM; Loureiro MPS; Lima JMB; Gress CH; Cabello GMK; Cabello PH; Borgonovo T; Vaz IM; Silva R; Mendez-Otero R
Stem Cell Res; 2019 Aug; 39():101490. PubMed ID: 31301488
[TBL] [Abstract][Full Text] [Related]
16. P.F508del editing in cells from cystic fibrosis patients.
Smirnikhina SA; Kondrateva EV; Adilgereeva EP; Anuchina AA; Zaynitdinova MI; Slesarenko YS; Ershova AS; Ustinov KD; Yasinovsky MI; Amelina EL; Voronina ES; Yakushina VD; Tabakov VY; Lavrov AV
PLoS One; 2020; 15(11):e0242094. PubMed ID: 33175893
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cell line (RCMGi012-A) from fibroblasts of patient with mucopolysaccharidosis type VI.
Kondrateva E; Grigorieva O; Panchuk I; Bychkov I; Zakharova E; Tabakov V; Pozhitnova V; Voronina E; Shchagina O; Lavrov A; Smirnikhina S; Kutsev S
Stem Cell Res; 2023 Dec; 73():103259. PubMed ID: 38006675
[TBL] [Abstract][Full Text] [Related]
18. Generation of an induced pluripotent stem cell line (DHMCi009-A) from an individual with TUBB2A tubulinopathy.
Schröter J; Syring H; Göhring G; Kölker S; Opladen T; Hoffmann GF; Syrbe S; Jung-Klawitter S
Stem Cell Res; 2022 Oct; 64():102879. PubMed ID: 35930870
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line (MHHi018-A) from a patient with Cystic Fibrosis carrying p.Asn1303Lys (N1303K) mutation.
Merkert S; Schubert M; Haase A; Janssens HM; Scholte B; Lachmann N; Göhring G; Martin U
Stem Cell Res; 2020 Apr; 44():101744. PubMed ID: 32220772
[TBL] [Abstract][Full Text] [Related]
20. Generation of two iPSC lines from patient with Mucopolysaccharidosis IV B type and autosomal recessive non-syndromic hearing loss 12.
Panchuk IO; Grigorieva OV; Kondrateva EV; Kurshakova EV; Tabakov V; Bychkov IO; Zakharova E; Orlova MD; Voronina ES; Pozhitnova VO; Lavrov AV; Smirnikhina SA; Kutsev SI
Stem Cell Res; 2023 Sep; 71():103183. PubMed ID: 37643494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
